Involvement of MT2 receptors in protective effects of melatonin against cisplatin-induced gastrointestinal damage in mice
DOI:
https://doi.org/10.1590/s2175-97902022e20476Keywords:
Gastric emptying, Gut motility, Gastrointestinal, ChemotherapyAbstract
Melatonin (MLT) reportedly reduces side effects associated with certain antineoplastic agents. Accordingly, we investigated the effect of MLT on cisplatin (CP)-induced gastric emptying (GE) delay. Mice were intraperitoneally pretreated with vehicle (ethanol 5%; control group), MLT (5, 10, or 20 mg/kg), or N-acetylcysteine (NAC; 150 mg/kg), followed by CP treatment (5 mg/kg). Pharmacological modulation was analyzed using relevant receptor antagonists (luzindole: non-selective MT1/MT2 antagonist; 5 mg/kg or 4-P-PDOT: selective MT2 antagonist; 4 mg/kg) before treatment with MLT plus CP. All treatments were performed once daily for three days. GE was assessed using phenol red. Gut morphology was examined using scanning electron microscopy and optical microscopy. Compared with the control, CP decreased GE. Pretreatment with NAC and MLT (5 and 10 mg/kg) did not prevent CP-induced gastric dysmotility; however, pretreatment with 20 mg/kg MLT prevented this effect. In addition, luzindole and 4-P-PDOT suppressed MLT-mediated gastroprotection against cytotoxic effects of CP. CP caused degeneration of the gut mucosa, which was attenuated by MLT treatment. Thus, 20 mg/kg MLT prevented the GE delay and decreased CP-induced adverse effects on the gut mucosa. In addition, the gastroprotective activity was mediated via the MT2 receptor.
Downloads
References
Abdel-Wahab WM, Moussa FI. Neuroprotective effect of N-acetylcysteine against cisplatin-induced toxicity in rat brain by modulation of oxidative stress and inflammation. Drug Des Devel Ther. 2019;13:1155-1162.
Anand H, Misro MM, Sharma SB, Prakash S. Protective effects of Eugenia jambolana extract versus N-acetyl cysteine against cisplatin-induced damage in rat testis. Andrologia. 2015;47(2):194-208.
Ando H, Mochiki E, Ohno T, Yanai M, Toyomasu Y, Ogata K, et al. Mechanism of gastrointestinal abnormal motor activity induced by cisplatin in conscious dogs. World J Gastroenterol. 2014;20(42):15691-702.
Ando K, Takagi K, Tsubone H. Enhanced gastric retention of solid resin beads as a marker for emetic potential of agents in rats. J Toxicol Sci. 2012;37(3):549-53.
Babu KG, Chaudhuri T, Lakshmaiah KC, Dasappa L, Jacob LA, Suresh Babu MC, et al. Modified Epirubicin, cisplatin, and 5-FU regimen as first-line chemotherapy in metastatic gastric or gastroesophageal junction adenocarcinoma: A Phase II study. South Asian J Cancer. 2019;8(2):85-87.
Bang CS, Yang YJ, Baik GH. Melatonin for the treatment of gastroesophageal reflux disease; protocol for a systematic review and meta-analysis. Medicine (Baltimore). 2019;98(4):e14241.
Barberino RS, Menezes VG, Ribeiro AEAS, Palheta RC Jr, Jiang X, Smitz JEJ, et al. Melatonin protects against cisplatin- induced ovarian damage in mice via the MT1 receptor and antioxidant activity. Biol Reprod. 2017;96(6):1244-1255.
Brzozowska I, Konturek PC, Brzozowski T, Konturek SJ, Kwiecien S, Pajdo R, et al. Role of prostaglandins, nitric oxide, sensory nerves and gastrin in acceleration of ulcer healing bymelatonin and its precursor, L-tryptophan. J Pineal Res. 2002;32(3):149-162.
Cabezos PA, Vera G, Martín-Fontelles MI, Fernández- Pujol R, Abalo R. Cisplatin-induced gastrointestinal dysmotility is aggravated after chronic administration in the rat. Comparison with pica. Neurogastroenterol Motil. 2010;22(7):797-805, e224-5.
Carrascal L, Nunez-Abades P, Ayala A, Cano M. Role of Melatonin in the Inflammatory Process and its Therapeutic Potential. Curr Pharm Des. 2018;24(14):1563-1588.
Chen C, Fichna J, Laudon M, Storr M. Antinociceptive Effects of Novel Melatonin Receptor Agonists in Mouse Models of Abdominal Pain. World J Gastroenterol . 2014;20(5):1298- 304.
Chen CQ, Fichna J, Bashashati M, Li YY, Storr M. Distribution, function and physiological role of melatonin in the lower gut. World J Gastroenterol . 2011;17(34):3888-98.
Farhood B, Aliasgharzadeh A, Amini P, Saffar H, Motevaseli E, Rezapoor S, et al. Radiation-Induced Dual Oxidase Upregulation in Rat Heart Tissues: Protective Effect of Melatonin. Medicina (Kaunas). 2019;55(7):317.
Flemstrom G, Sjoblom M. Epithelial cells and their neighbors. II. New perspectives on efferent signaling between brain, neuroendocrine cells, and gut epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2005;289(3):G377-380.
Ginzac A, Dubois S, Hager MO, Kwiatkowski F, Passildas J, Biau J, et al. Quality of life for older patients with cancer: a review of the evidence supporting melatonin use. Aging Clin Exp Res. 2020;32(12):2459-2468.
Guo F, Xu L, Gao S, Sun X, Zhang N, Gong Y. Effect of orexin-A in the Arcuate Nucleus on Cisplatin-Induced Gastric Side Effects in Rats. Neurosci Res. 2019;143:53-60.
Han D, Wang Y, Chen J, Zhang J, Yu P, Zhang R, Li S, et al. Activation of melatonin receptor 2 but not melatonin receptor 1 mediates melatonin-conferred cardioprotection against myocardial ischemia/reperfusion injury. J Pineal Res . 2019;67(1):e12571.
Hegab II, Abd-Ellatif RN, Sadek MT. The gastroprotective effect of N-acetylcysteine and genistein in indomethacin- induced gastric injury in rats. Can J Physiol Pharmacol. 2018;(96):1161-1170.
Kasimay O, Cakir B, Devseren E, Yegen BC. Exogenous melatonin delays gastric emptying rate in rats: role of CCK2 and 5-HT3 receptors. J Physiol Pharmacol. 2005;56(4):543- 53.
Kim JW, Jo J, Kim JY, Choe M, Leem J, Park JH. Melatonin Attenuates Cisplatin-Induced Acute Kidney Injury through Dual Suppression of Apoptosis and Necroptosis. Biology (Basel). 2019;30;8(3):64.
Ko JL, Tsai CH, Liu TC, Lin MY, Lin HL, Ou CC. Differential effects of grape juice on gastric emptying and renal function from cisplatin-induced acute adverse toxicity. Hum Exp Toxicol. 2016;35(8):808-817.
Konturek PC, Brzozowska I, Targosz A, Pawlik M, Kania J, Hess T, et al. Esophagoprotection mediated by exogenous and endogenous melatonin in an experimental model of reflux esophagitis. J Pineal Res . 2013;55(1):46-57.
Konturek SJ, Konturek PC, Brzozowska I, Pawlik M, Sliwowski Z, Cześnikiewicz-Guzik M, et al. Localization and biological activities of melatonin in intact and diseased gastrointestinal tract (GIT). J Physiol Pharmacol . 2007;58(3):381-405.
Liu Y, Zhang S, Ye F, Yin J, Li S, Chen JDZ. Ameliorating effects and mechanisms of chronic electroacupuncture at ST36 in a rodent model of dyspepsia induced by cisplatin. Neurogastroenterol Motil . 2019;31(1):e13474.
Lu F, Wang F, Chen Z, Huang H. Effect of mesenchymal stem cells on small intestinal injury in a rat model of acute necrotizing pancreatitis. Stem Cell Res Ther. 2017;8(1):12.
Lu KH, Lin RC, Yang JS, Yang WE, Reiter RJ, Yang SF.. Molecular and Cellular Mechanisms of Melatonin in Osteosarcoma. Cells. 2019;8(12):1618.
Madhu P, Reddy KP, Reddy PS. Melatonin reduces oxidative stress and restores mitochondrial function in the liver of rats exposed to chemotherapeutics. J Exp Zool A Ecol Genet Physiol. 2015;323(5):301-8.
Monti D, Sotgia F, Whitaker-Menezes D, Tuluc M, Birbe R, Berger A, et al. Pilot study demonstrating metabolic and anti- proliferative effects of in vivo anti-oxidant supplementation with N-Acetylcysteine in Breast Cancer. Semin Oncol. 2017;44(3):226-232z.
Muldoon LL, Wu YJ, Pagel MA, Neuwelt EA. N-acetylcysteine chemoprotection without decreased cisplatin antitumor efficacy in pediatric tumor models. J Neurooncol. 2015;121(3):433-40.
Nam Y, Lee JM, Wang Y, Ha HS, Sohn UD. The effect of Flos Lonicerae Japonicae extract on gastro-intestinal motility function. J Ethnopharmacol. 2016;179:280-90.
Pandit A, Kim HJ, Oh GS, Shen A, Lee SB, Khadka D, et al. Dunnione ameliorates cisplatin-induced small intestinal damage by modulating NAD(+) metabolism. Biochem Biophys Res Commun. 2015;467(4):697-703.
Pini A, Garella R, Idrizaj E, Calosi L, Baccari MC, Vannucchi MG. Glucagon-like peptide 2 counteracts the mucosal damage and the neuropathy induced by chronic treatment with cisplatin in the mouse gastric fundus. Neurogastroenterol Motil . 2016;28(2):206-16.
Reiter RJ, Mayo JC, Tan DX, Sainz RM, Alatorre-Jimenez M, Qin L. Melatonin as an antioxidant: under promises but over delivers. J Pineal Res . 2016;61(3):253-78.
Riyaz A, Nazir S, Khushtar M, Mishra A, Jahan Y, Ahmad A. Effect of Nigella sativa L. seed extract on cisplatin-induced delay in gastric emptying in Sprague-Dawley rats. Nat Prod Res. 2017;31(5):588-592.
Shahid F, Farooqui Z, Khan F. Cisplatin-induced gastrointestinal toxicity: An update on possible mechanisms and on available gastroprotective strategies. Eur J Pharmacol. 2018;827:49-57.
Shahrokhi N, Khaksari M, Nourizad S, Shahrokhi N, Soltani Z, Gholamhosseinian A. Protective effects of an interaction between vagus nerve and melatonin on gastric ischemia/ reperfusion: the role of oxidative stress. Iran J Basic Med Sci. 2016;19(1):72-9.
Shin SJ, Kim D, Kim JS, Kim I, Lee JR, Kim SC, et al. Effects of Gamisoyo-San Decoction, a Traditional Chinese Medicine, on Gastrointestinal Motility. Digestion. 2018;98(4):231-237.
Siah KTH, Wong RKM, Ho KY. Melatonin for the treatment of irritable bowel syndrome. World J Gastroenterol . 2014;20(10):2492-8.
Silva CM, Wanderley CW, Lima-Junior FJ, de Sousa DP, Lima JT, Magalhães PJ, et al. Carvone (R)-(-) and (S)-(+) enantiomers inhibits upper gastrointestinal motility in mice. Flavour Fragr J. 2015;30(6):439-444.
Singh M, Jadhav HR. Melatonin: functions and ligands. Drug Discov Today. 2014;19(9):1410-8.
Sjöblom M, Flemström G. Central nervous stimuli increase duodenal bicarbonate secretion by release of mucosal melatonin. J Physiol Pharmacol . 2001;52(4 Pt 1):671-8.
Söderquist F, Hellström PM, Cunningham JL. Human gastroenteropancreatic expression of melatonin and its receptors MT1 and MT2. PLoS One. 2015;10(3):e0120195.
Stebelová K, Anttila K, Mänttäri S, Saarela S, Zeman M. Immunohistochemical definition of MT(2) receptors and melatonin in the gastrointestinal tissues of rat. Acta Histochem. 2010;112(1):26-33.
Stojanovska V, Sakkal S, Nurgali K. Platinum-based chemotherapy: gastrointestinal immunomodulation and enteric nervous system toxicity. Am J Physiol Gastrointest Liver Physiol . 2015;308(4):G223-32.
Tamura H, Takasaki A, Taketani T, Tanabe M, Kizuka F, Lee L, et al. Melatonin as a free radical scavenger in the ovarian follicle. Endocr J. 2013;60(1):1-13.
Thor PJ, Krolczyk G, Gil K, Zurowski D, Nowak L. Melatonin and serotonin effects on gastrointestinal motility. J Physiol Pharmacol . 2007;58(Suppl 6):97-103.
Uranga JA, García-Martínez JM, García-Jiménez C, Vera G, Martín-Fontelles MI, Abalo R. Alterations in the small intestinal wall and motor function after repeated cisplatin in rat. Neurogastroenterol Motil . 2017;29(7).
Vera G, Castillo M, Cabezos PA, Chiarlone A, Martín MI, Gori A, et al. Enteric neuropathy evoked by repeated cisplatin in the rat. Neurogastroenterol Motil . 2011;23(4):370-8, e162-3.
Viana-Cardoso KV, da Silva MT, Júnior RC, Peixoto Junior AA, Pinho LG, Santos AA, et al. Repeated cisplatin treatments inhibit gastrointestinal motility and induces baroreflex changes and mechanical hyperalgesia in rats. Cancer Invest. 2011;29(7):494-500.
Wongprayoon P, Govitrapong P. Melatonin receptor as a drug target for neuroprotection. Curr Mol Pharmacol. 2021;14(2):150-164.
Zhu D, Ma Y, Ding S, Jiang H, Fang J. Effects of Melatonin on Intestinal Microbiota and Oxidative Stress in Colitis Mice. Biomed Res Int. 2018;2018:2607679.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
